Pulse Biosciences Inc. (PLSE)
Pulse Biosciences Statistics
Share Statistics
Pulse Biosciences has 61.52M shares outstanding. The number of shares has increased by 11.39% in one year.
Shares Outstanding | 61.52M |
Shares Change (YoY) | 11.39% |
Shares Change (QoQ) | 0% |
Owned by Institutions (%) | 9.76% |
Shares Floating | 11.49M |
Failed to Deliver (FTD) Shares | 137 |
FTD / Avg. Volume | 0.08% |
Short Selling Information
The latest short interest is 2.13M, so 3.46% of the outstanding shares have been sold short.
Short Interest | 2.13M |
Short % of Shares Out | 3.46% |
Short % of Float | 18.45% |
Short Ratio (days to cover) | 13.84 |
Valuation Ratios
The PE ratio is -18.97 and the forward PE ratio is -21.48. Pulse Biosciences's PEG ratio is -4.17.
PE Ratio | -18.97 |
Forward PE | -21.48 |
PS Ratio | 0 |
Forward PS | 28.5 |
PB Ratio | 8.85 |
P/FCF Ratio | -27.88 |
PEG Ratio | -4.17 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Pulse Biosciences.
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.88, with a Debt / Equity ratio of 0.08.
Current Ratio | 11.88 |
Quick Ratio | 11.88 |
Debt / Equity | 0.08 |
Debt / EBITDA | -0.16 |
Debt / FCF | -0.24 |
Interest Coverage | 0 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity | n/a |
Return on Assets | n/a |
Return on Invested Capital | n/a |
Revenue Per Employee | $0 |
Profits Per Employee | $-714.47K |
Employee Count | 75 |
Asset Turnover | 0 |
Inventory Turnover | n/a |
Taxes
Income Tax | 0 |
Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 107.54% in the last 52 weeks. The beta is 1.63, so Pulse Biosciences's price volatility has been higher than the market average.
Beta | 1.63 |
52-Week Price Change | 107.54% |
50-Day Moving Average | 18.68 |
200-Day Moving Average | 17.38 |
Relative Strength Index (RSI) | 38.69 |
Average Volume (20 Days) | 172.89K |
Income Statement
Revenue | n/a |
Gross Profit | 0 |
Operating Income | -56.26M |
Net Income | -53.59M |
EBITDA | -56.26M |
EBIT | n/a |
Earnings Per Share (EPS) | -0.92 |
Balance Sheet
The company has 118.04M in cash and 8.9M in debt, giving a net cash position of 109.14M.
Cash & Cash Equivalents | 118.04M |
Total Debt | 8.9M |
Net Cash | 109.14M |
Retained Earnings | -390.5M |
Total Assets | 93.05M |
Working Capital | 73.67M |
Cash Flow
In the last 12 months, operating cash flow was -36.34M and capital expenditures -125K, giving a free cash flow of -36.47M.
Operating Cash Flow | -36.34M |
Capital Expenditures | -125K |
Free Cash Flow | -36.47M |
FCF Per Share | -0.62 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
PLSE does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Payout Ratio | n/a |
Earnings Yield | n/a |
FCF Yield | n/a |
Analyst Forecast
Currently there are no analyst rating for PLSE.
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Scores
Altman Z-Score | 35.28 |
Piotroski F-Score | 3 |